Shares of Merck & Co. Inc. MRK slipped 1.73% to $85.99 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.71% to 6,552.51 and ...

Merck headquarters in Rahway, NJ. RAHWAY, N.J.- Merck has completed its $10 billion buyout of the British biopharmaceutical company Verona. The deal was first announced in July. It brings the chronic ...

RAHWAY, N.J. - Merck (NYSE:MRK), a prominent player in the pharmaceutical industry with a market capitalization of $222.78 billion and an impressive gross profit margin of 77.41%, has initiated three ...

Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...

Merck & Co. Inc. (NYSE:MRK) on Thursday released results from the Phase 3 STRIDE-13 trial evaluating Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) at the European Society of Clinical ...

Thank you very much for joining us today for the lunch session. My name is Mohit Bansal. I'm Biotech and Pharma Analyst here at Wells Fargo. And I'm very happy to have the Merck management team with ...

Merck & Co. and Bayer’s Verquvo failed to deliver a composite cardiovascular benefit for certain patients with stable heart failure with reduced ejection fraction (HFrEF). The phase 3 Victor trial ...

Shares of Merck & Co. Inc. slumped Tuesday, after the drug giant reported a rare revenue miss amid disappointing sales of two of its three biggest drugs and announced a $3 billion cost-cutting plan ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst ...

Stock falls after a rare quarterly revenue miss, as Keytruda sales beat expectations but Gardasil sales fell well below forecasts Shares of Merck & Co. Inc. slumped Tuesday, after the drug giant ...